Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05214365 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy

Study acronym: PHYSPAVB
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Study completion pushed from Sep 1, 2026 to Dec 1, 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 3 of 11 entries
    • Site details revised
    • Collaborators: details revised at 1 of 2 entries
  2. Primary completion date: Sep 1, 2025 to Sep 1, 2026v8
  3. Primary completion date: Jun 1, 2025 to Sep 1, 2025
    • Study completion date: Jun 1, 2026 to Sep 1, 2026
    v7
  4. Site details revisedv6
  5. Primary completion date: Dec 1, 2024 to Jun 1, 2025
    • Study completion date: Dec 1, 2025 to Jun 1, 2026
    • Site details revised
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Feb 1, 2024 to Dec 1, 2024
    • Study completion date: Jun 1, 2024 to Dec 1, 2025
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 7 more changesShow less
    • Primary completion date: Jun 3, 2023 to Feb 1, 2024
    • Study completion date: Jun 3, 2024 to Jun 1, 2024
    • Start date changed from estimate of Jan 24, 2022 to Feb 1, 2022
    • Secondary endpoints: details revised at 6 of 11 entries
    • Study site revised
    • Study description expanded, about 1 word
    • Study title expanded, about 1 word
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.
Trial Details
NCT Number NCT05214365
Lead Sponsor Hospital Clinic of Barcelona
Collaborators: Institut d'Investigacions Biomèdiques August Pi i Sunyer, Consorcio Centro de Investigación Biomédica en Red (CIBER)
Conditions
(from sponsor)		 Conduction System Pacing, Conventional Ventricular Pacing
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov